{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["77"],"submitter":["Kiritsi D"],"funding":["Deutsche Forschungsgemeinschaft","DEBRA International","Universitätsmedizin der Johannes Gutenberg-Universität Mainz","Albert-Ludwigs-Universität Freiburg"],"journal":["EClinicalMedicine"],"pagination":["102900"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11558043"],"repository":["biostudies-literature"],"pubmed_title":["Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial."],"pmcid":["PMC11558043"],"funding_grant_id":["SFB-1479","SFB1160","441891347","KI1795/2-1"],"pubmed_authors":["Stiller B","Nystrom A","Bruckner-Tuderman L","Reimer-Taschenbrecker A","Kiritsi D","Grishina O","Schauer F","Reineker K","Murrell D","Ott H","Zahn T","Schmoor C","Gewert S","Schwieger-Briel A"],"additional_accession":[]},"is_claimable":false,"name":"Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial.","description":null,"dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2026-06-03T03:23:30.519Z","creation":"2025-04-06T22:44:42.51Z"},"accession":"S-EPMC11558043","cross_references":{"pubmed":["39539991"],"doi":["10.1016/j.eclinm.2024.102900"]}}